News
- Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
16:00 - GlobeNewswire
-
- ROSEN, A LEADING LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GDRX
16:00 - GlobeNewswire
-
- ROSEN, A TRUSTED LAW FIRM, Reminds Covia Holdings Corporation f/k/a Fairmount Santrol Holdings Inc. Investors of Important February 8 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CVIAQ, CVIA, FMSA
15:00 - GlobeNewswire
-
- Investor Reminder: Kessler Topaz Meltzer & Check, LLC Reminds Investors of Splunk Inc. of Fast Approaching Deadline
01/16/2021 / 21:13 - GlobeNewswire
-
- ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV
01/16/2021 / 20:54 - GlobeNewswire
-
- Google investigates Android COVID tracking app issues
01/13/2021 / 19:46 - TeleTrader
-
- Freddie Mac Prices $1 Billion Multifamily K-Deal, K-F96
01/06/2021 / 21:46 - GlobeNewswire
-
- Google employees to create labor union
01/04/2021 / 12:50 - TeleTrader
-
- Axsome Therapeutics Announces Positive Efficacy and Safety Results from the Phase 3 MOVEMENT Long-Term Trial of AXS-07 in the Acute Treatment of Migraine
12/31/2020 / 12:00 - GlobeNewswire
-
- Banco Santander-Chile Announces Fourth Quarter 2020 Analyst and Investor Webcast / Conference Call
12/28/2020 / 18:08 - GlobeNewswire
Real-time